Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.78USD
14 Dec 2018
Change (% chg)

$-0.09 (-3.14%)
Prev Close
$2.87
Open
$2.83
Day's High
$2.93
Day's Low
$2.76
Volume
200,888
Avg. Vol
555,817
52-wk High
$5.05
52-wk Low
$1.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.38 -0.208
Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 1.70 8.50 0.20 3.27
Quarter Ending Mar-19 4 0.53 1.10 0.20 --
Year Ending Dec-18 7 3.05 10.00 1.74 14.60
Year Ending Dec-19 8 8.43 13.30 4.85 27.65
Earnings (per share)
Quarter Ending Dec-18 6 -0.21 -0.14 -0.24 -0.23
Quarter Ending Mar-19 5 -0.24 -0.20 -0.27 --
Year Ending Dec-18 6 -0.86 -0.77 -0.92 -1.02
Year Ending Dec-19 8 -0.97 -0.71 -1.24 -0.74
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 1.92 0.66 0.95
Price to Sales (TTM) 112.49 242.95 21.76
Price to Book (MRQ) -- 18.87 4.53
Price to Tangible Book (MRQ) -- 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -74.65 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -83.36 61.53 5.26
Sales - 5 Yr. Growth Rate 27.27 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.02 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 85.93 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate 23.83 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.50 3.57 2.63
Current Ratio (MRQ) 4.56 6.87 3.68
LT Debt to Equity (MRQ) -- 16.70 9.53
Total Debt to Equity (MRQ) -- 21.89 13.39
Interest Coverage (TTM) -13.14 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -62.42 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -1,394.47 -- --
EBITD - 5 Yr. Avg -159.97 -141.70 16.27
Operating Margin (TTM) -1,429.19 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -170.05 -155.53 11.89
Pre-Tax Margin (TTM) -1,983.19 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -221.62 -157.11 12.22
Net Profit Margin (TTM) -455.36 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -178.66 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 55,561 28,103,806 878,349,382
Net Income/Employee (TTM) -253,000 -3,710,889 102,474,711
Receivable Turnover (TTM) 2.98 9.19 5.49
Inventory Turnover (TTM) 4.05 2.64 3.99
Asset Turnover (TTM) 0.03 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -12.93 0.35 11.06
Return on Assets - 5 Yr. Avg. -28.68 2.90 11.85
Return on Investment (TTM) -15.82 0.60 13.80
Return on Investment - 5 Yr. Avg. -32.46 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -96.91 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -53.94 15.29 27.27
EPS (TTM) % 61.02 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.57 -11.55 25 99
13 Week 14.67 23.87 89 94
26 Week 2.69 2.98 76 96
52 Week 56.36 51.66 85 98
YTD 69.88 69.33 91 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.27%
# of Holders: 70
Total Shares Held: 7,653,221
3 Mo. Net Change: 1,840,145
# New Positions: 16
# Closed Positions: 13
# Increased Positions: 43
# Reduced Positions: 24
# Net Buyers: 19
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.